Hunan Huateng Pharmaceutical

Hunan Huateng Pharmaceutical Co., Ltd founded in 2013, is a one-stop a contract development and manufacturing organization (CDMO) to manufacture and supply researchers with PEG derivatives and products used across the pharmaceutical value chain including intermediates, excipients, APIs, and reagents.

Life Sciences, BioTech/BioPharmaceutical

Advertise with us

Basic Information

Huateng Pharma has established a 5000 square meters R&D center , equipped with nearly 100 sets of high-end analytical and testing instruments and automatic reaction equipment, such as 400 MHz NMR system, Agilent LC/MS, Waters HPLC, Agilent Intelligent GC system, etc., which can ensure fast and efficient completion of various customized orders from customers. Huateng Pharma employs more than 400 full time staff, including more than 160 professional researchers of which approximately 60% are Ph.D.'s and MSc's.

Legal Name

Hunan Huateng Pharmaceutical Co Ltd

Headquarters

Changsha, Hunan, China

Business Model

B2B

Founding Date

2013

No. of Employees

251 to 500

Core Team

Deng Zeping

Founder

Timeline

2019

Sep | Raised Funding

Huateng Pharmaceutical Raised 50 Million Yuan in the Series A Round of Funding.

2021

Apr | Raised Funding

Huateng Pharma Completed Series B Round of Financing.

Revenue Stream

Selling data

Advertise with us

Target Market

B2B

A one-stop a contract development and manufacturing organization (CDMO) to manufacture and supply researchers with PEG derivatives and products used across the pharmaceutical value chain.

Client Segment

BioTech/BioPharmaceutical, Life Sciences

Target Companies

Startup, Small Enterprise, Medium Enterprise, Large Enterprise

Target Geography

India, Global, Europe, North America

Advertise with us

Funding

Total Funding

$26.0M

Investors

CITIC Securities